Christina Gross Joins Endpoint, Bringing 25 Years of Surgical Expertise

March 18, 2025

With surgical expertise spanning cardiovascular, neurological, and reconstructive procedures, Christina brings a hands-on, results-driven approach to advancing preclinical research. Her deep knowledge in complex surgical models and interventional techniques empowers research teams to refine procedures, optimize workflows, and drive meaningful innovation in medical device development.

Endpoint Preclinical is proud to welcome Christina (Tina) Gross, BA, SRS, to our Expert Network. A highly skilled preclinical surgeon and study director, Tina has spent more than two decades performing advanced surgical and interventional procedures across a wide range of therapeutic areas. Her experience includes complex cardiovascular interventions, transplant procedures, reconstructive models, and next-generation neurosurgical techniques. She will provide expert consulting, surgical execution, and study design services to help research teams achieve reproducible, high-quality results in preclinical studies. View Christina’s Profile

Tina’s extensive background in preclinical research and medical device development makes her a trusted leader in surgical innovation. She has worked on thousands of procedures, from aortic valve replacements and vascular grafting to deep brain stimulation and orthopedic repair. Her hands-on expertise in cardiovascular device testing, reconstructive surgery, and hybrid interventional techniques allows her to create and refine clinically relevant models that bridge the gap between research and real-world application.

Beyond her technical proficiency, Tina has spent over 15 years as a GLP Study Director, overseeing complex preclinical studies with a meticulous approach to protocol development and regulatory compliance. She excels at integrating surgical expertise with engineering considerations, ensuring medical technologies are rigorously tested under controlled yet clinically meaningful conditions. Her ability to adapt quickly to new procedures, troubleshoot technical challenges, and streamline workflows has made her an invaluable partner for research teams and medical device developers.

Preclinical research isn’t just about technical execution—it’s about driving real-world impact. Tina’s passion for advancing surgical innovation became deeply personal when her own father received a stent she had helped develop. This experience reinforced her dedication to ensuring preclinical research leads to safer, more effective medical advancements. Her philosophy centers on precision, efficiency, and patient-centered progress, and she thrives on helping research teams refine their methodologies to bring life-changing technologies to market.

I am excited to join Endpoint Preclinical’s Expert Network and collaborate with teams who are pushing the boundaries of medical innovation.

With 25 years in preclinical research, I am passionate about refining complex surgical models, optimizing study designs, and ensuring the highest level of procedural integrity.

I look forward to working alongside research teams to overcome challenges, refine techniques, and contribute to groundbreaking advancements in medical science. — Tina Gross

Tina’s expertise extends beyond surgical execution—she is a leader in training, protocol development, and experimental design. She works closely with research teams to develop robust study protocols, troubleshoot technical challenges, and optimize surgical workflows to ensure reproducibility and high-quality outcomes. Her deep understanding of regulatory requirements allows her to provide strategic guidance on risk assessment, study oversight, and medical device validation.

Her work supports a wide range of preclinical research applications, including cardiovascular device development, transplant procedures, regenerative medicine, and neurological interventions. With expertise in fluoroscopy, IVUS, OCT, ultrasound imaging, cardiopulmonary bypass (CPB) machines, and hemodynamic monitoring, she brings a critical technical edge to preclinical research, ensuring studies are not only well-executed but also clinically meaningful.

We are excited to have Tina as part of the Endpoint Preclinical team. Her ability to combine expert surgical execution with strategic study oversight will elevate our capacity to support innovative medical research. To learn how her expertise can support your preclinical studies, contact us today.